Lutz Frankenstein
Advanced in Congenital Pulmonary Lymphangiectasia

Lutz Frankenstein

Heidelberg, BW, DE 
Advanced in Congenital Pulmonary Lymphangiectasia
Heidelberg, BW, DE 
OverviewLocationsClinical Research

Overview

Lutz Frankenstein practices in Heidelberg, Germany. Mr. Frankenstein is rated as an Advanced expert by MediFind in the treatment of Congenital Pulmonary Lymphangiectasia. His top areas of expertise are Heart Failure, Dilated Cardiomyopathy (DCM), Cardiomyopathy, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 104 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Congenital Pulmonary Lymphangiectasia.

Gender
Male

Locations

Heidelberg, BW 69120, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicentre, Prospective Registry to Evaluate the Safety and Efficacy of Minimally Invasive Ultrafiltration Treatment and Its Effect on Symptoms and Rehospitalisation in Patients With Advanced Volume Overload
A Multicentre, Prospective Registry to Evaluate the Safety and Efficacy of Minimally Invasive Ultrafiltration Treatment and Its Effect on Symptoms and Rehospitalisation in Patients With Advanced Volume Overload
Enrollment Status: Terminated
Publish Date: August 05, 2021
Intervention Type: Device
PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure
PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure
Enrollment Status: Terminated
Publish Date: May 05, 2021
Intervention Type: Other, Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

104 Total Publications

Endothelial dysfunction assessed by the endothelial activation and stress index (EASIX) predicts risk of mortality in chronic heart failure patients.
Endothelial dysfunction assessed by the endothelial activation and stress index (EASIX) predicts risk of mortality in chronic heart failure patients.
Journal: International journal of cardiology
Published: May 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Frankenstein's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile